FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking FDA takes first step in possible reversal of ban on some peptides The Washington Post Is BPC 157 Legal? Understanding Its Status and Implications